Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.
Authors:
- R M BellRBR M Bell
Open Access
- 1 February 1988
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 263 (4) , 1682-1692
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Inhibition of proto-oncogene c-fos transcription by inhibitors of protein kinase C and ion transportEuropean Journal of Biochemistry, 1987
- Inhibitors of protein kinase C block the α1‐adrenergic refractoriness induced by phorbol 12‐myristate 13‐acetate, vasopressin and angiotensin IIEuropean Journal of Biochemistry, 1987
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986
- Rapid purification of protein kinase C by high performance liquid chromatographyBiochemical and Biophysical Research Communications, 1986
- Kinetic evidence that 1,2-diolein inhibits phorbol ester binding to protein kinase C via a competitive mechanismBiochemical and Biophysical Research Communications, 1985
- A model for intracellular translocation of protein kinase C involving synergism between Ca2+ and phorbol estersNature, 1985
- Inhibition of phospholipid/Ca2+-dependent protein kinase and phosphorylation of leukemic cell proteins by CP-46, 665-1, a novel antineoplastic lipoidal amineBiochemical and Biophysical Research Communications, 1985
- 1-(5-isoquinol inesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase c in rabbit plateletsBiochemical and Biophysical Research Communications, 1984
- Effect of 2-β-d-ribofuranosylthiazole-4-carboxamide on uptake of nucleosides by cultured L1210 cellsCancer Letters, 1984
- Inositol phospholipids in membrane functionTrends in Biochemical Sciences, 1979